A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

Clinical trial NCT06484920 · RECRUITING

Trial details

NCT number: NCT06484920
Sponsor: Rita Assi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma B-cell Lymphoma

Start date: 2024-11-18
Primary completion: 2027-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.